HealthEquity Inc stock (US42226C1071): Shares trade near recent highs after strong FY 2025 results

HealthEquity shares on Nasdaq remain supported after the company reported double-digit revenue growth and higher adjusted earnings for fiscal 2025 in March 2025, highlighting the United States-based HSA specialist’s expanding scale in health savings administration.

HealthEquity Inc stock is trading in the upper part of its recent range on the Nasdaq in the United States after the company reported solid fiscal 2025 results in March 2025, with double-digit top-line growth and higher profitability underscoring ongoing demand for its health savings account services according to the company’s earnings release dated 03/19/2025HealthEquity IR as of 03/19/2025.

The stock traded at USD 93.23 on 06/05/2026 on Nasdaq, according to Nasdaq quote data as of that dateNasdaq as of 06/05/2026.

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: HealthEquity Inc
• Sector/industry: Health savings accounts and benefits administration
• Headquarters/country: Draper, United States
• Core markets: United States employer-sponsored health benefits
• Key revenue drivers: HSA custodial and service fees, interchange revenue, and related benefits administration services
• Home exchange/listing venue: Nasdaq (HQY)
• Trading currency: USD

HealthEquity Inc: core business model

HealthEquity generates most of its business by providing cloud-based platforms and services that help U.S. employers and individuals manage health savings accounts and related consumer-directed benefits, earning revenue primarily from custodial fees, service charges and payment-related income.

Latest quarterly results for HealthEquity Inc at a glance

In its results for the fourth quarter and full fiscal year ended 01/31/2025, released on 03/19/2025, HealthEquity reported revenue of USD 288.1 million for the quarter, up from USD 257.0 million in the same period a year earlier according to the company’s earnings releaseHealthEquity IR as of 03/19/2025.

For the full fiscal year 2025, the company stated that revenue reached USD 1.09 billion and that adjusted net income attributable to common stockholders was USD 210.6 million, compared with USD 135.2 million in fiscal 2024, reflecting the scaling of its HSA platform and higher yields on custodial cash according to the same 03/19/2025 releaseHealthEquity IR as of 03/19/2025.

Conclusion

HealthEquity Inc’s shares on Nasdaq are trading near recent highs after the United States-based HSA specialist delivered higher revenue and adjusted earnings for fiscal 2025, supported by growth in accounts and custodial cash yields as detailed in its 03/19/2025 results.

The latest quarterly and full-year figures give investors concrete reference points on the company’s scale in the U.S. benefits market, while the current share price provides a snapshot of how the market is valuing that growth profile as of early June 2026.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.